Letters and Correspondence
Osteoporosis in severe congenital neutropenia: Inherent to the disease or a sequela of G-CSF treatment?
Martin Simon,
Corresponding Author
Martin Simon
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author Eva Lengfelder,
Eva Lengfelder
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author Sebastian Reiter,
Sebastian Reiter
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author Rudiger Hehlmann,
Rudiger Hehlmann
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author
Martin Simon,
Corresponding Author
Martin Simon
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author Eva Lengfelder,
Eva Lengfelder
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author Sebastian Reiter,
Sebastian Reiter
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author Rudiger Hehlmann,
Rudiger Hehlmann
III Medizinische Klinik, Klinikum Mannheim, Mannheim, Germany
Search for more papers by this author
First published: June 1996
No abstract is available for this article.
References
- 1
Bishop NJ,
Williams DM,
Compston JC,
Stirling DM,
Prentice A:
Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor.
Br J Haematol
89: 927–928,
1995.
- 2
Zeidler C,
Reiter A,
Yakisan E,
Koci B,
Riehm H,
Welte K:
Langzeitbehandlung mit rekombinantem humanen Granulozyten-Kolonien stimulierenden Faktor bei Patienten mit schwerer kongenitaler Neutropenie.
Klin Padiatr
205: 264–271,
1993.
- 3
Bonilla MA,
Dale D,
Zeidler C,
Last L,
Reiter A,
Ruggeiro M,
Davis M, et al.:
Long-term safety of treatment with recombinant human granulocyte colonystimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.
Br J Haematol
88: 723–730.
1994.
- 4
Dale DC,
Bonilla MA,
Davis MW,
Nakanishi AM,
Hammond WP,
Kurtzberg J,
Wang W,
Jakuboswski A, et al.:
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
Blood
81: 2496–2502,
1993.
